Akeso, Inc. announces that the Ligufalimab (CD47 monoclonal antibody, research and development code: AK117, the novel immuno-oncology drug independently developed by the Company) and...
COVID-19 has irrevocably changed the landscape of the healthcare industry. The rapid digitalization of this industry has demonstrated that we as consumers have quickly...
Medline announced today the launch of its Vascular Access Health Solution, a new central line-associated bloodstream infection (CLABSI) prevention solution driven by human factors-based...
Lupin Pharmaceuticals Inc., (Lupin), and Exeltis USA Inc. announced a promotional agreement for Exeltis to promote SOLOSEC® along with Exeltis' existing line of Women's...
